Trial NCT04895046

View at ClinicalTrials.gov 
Org. Study IDs: HCRN GI19-414

Last trial update was posted on 2022-06-29

MeSH Interventions

Dostarlimab Niraparib

MeSH Conditions

Cholangiocarcinoma

Other Conditions

HRD Metastatic Cancer

Stopping Reasons

Funder decision

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID